\
&
Contact us
This was 2 weeks ago
LocationOnline
ProgrammesThis MSCA Radiance webinar is dedicated to researchers planning to apply for the MSCA Postdoctoral Fellowships with a Widening Country.
This session will include:
Information on Widening Countries is available on the European Commission Research Executive Agency website here.
All information related to this webinar, including the registration form and full agenda, is available in the announcement on the Horizon Europe NCP Portal website.
Agenda in brief (CET)
9.30 Welcome and introduction
9.35 PF highlights
9.45 Presentation of opportunities in Malta
9.55 Presentation of opportunities in Poland
10.05 Presentation of opportunities in Estonia
10.15 Presentation of opportunities in Lithuania
10.25 Presentation of opportunities in Bulgaria
10.35 Questions and answers
11.00 End of event
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.